BRIEF published on 12/02/2024 at 09:05, 1 year 9 months ago Eckert & Ziegler Initiates Actinium-225 Production to Tackle Global Shortage Nuclear Medicine Radiopharmaceuticals Actinium-225 Production Isotope Supply GMP Certification
BRIEF published on 12/02/2024 at 09:05, 1 year 9 months ago Eckert & Ziegler lance la production d'actinium 225 pour faire face à la pénurie mondiale Produits Radiopharmaceutiques Médecine Nucléaire Production D'actinium 225 Approvisionnement En Isotopes Certification GMP
PRESS RELEASE published on 12/02/2024 at 09:00, 1 year 9 months ago Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply Eckert & Ziegler starts Actinium-225 production in collaboration with Czech Academy of Sciences, aiming for GMP-grade supply to boost alpha-emitting radiopharmaceuticals development Eckert & Ziegler Production Radiopharmaceuticals Actinium-225 GMP-grade
BRIEF published on 11/27/2024 at 09:05, 1 year 9 months ago Eckert & Ziegler Gains European Approval for Theralugand® Cancer Therapy Radiopharmaceuticals Lutetium-177 European Approval Theralugand®
BRIEF published on 11/27/2024 at 09:05, 1 year 9 months ago Eckert & Ziegler obtient l'approbation européenne pour Theralugand® Produits Radiopharmaceutiques Thérapie Contre Le Cancer Lutetium-177 Theralugand® Agrément Européen
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year 9 months ago Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a) Eckert & Ziegler receives EC approval for Theralugand® - Lutetium-177 Chloride, expanding cancer therapy options in Europe Eckert & Ziegler Cancer Therapy EC Approval Theralugand Lutetium-177 Chloride
BRIEF published on 11/22/2024 at 15:32, 1 year 10 months ago Eckert & Ziegler Increases 2024 Financial Forecast Eckert & Ziegler Sales Increase Financial Forecast EBIT Growth 2024 Business
BRIEF published on 11/22/2024 at 15:32, 1 year 10 months ago Eckert & Ziegler augmente ses prévisions financières pour 2024 Eckert & Ziegler Prévisions Financières Augmentation Des Ventes Croissance Du Résultat D'exploitation (EBIT) Entreprise 2024
PRESS RELEASE published on 11/22/2024 at 15:27, 1 year 10 months ago EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again Eckert & Ziegler SE raises its forecast for the current financial year with sales of EUR 290 million and EBIT of EUR 60 million. Investor contact: Karolin Riehle, EZAG Financial Year Forecast Eckert & Ziegler SE EUR 290 Million EBIT EUR 60 Million
BRIEF published on 11/14/2024 at 07:50, 1 year 10 months ago Eckert & Ziegler Reports Strong Growth in First Nine Months of 2024 Eckert & Ziegler 2024 Forecast Financial Growth Medical Segment Isotope Products
Published on 09/23/2026 at 00:00, 44 minutes ago Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/23/2026 at 00:00, 44 minutes ago Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
Published on 09/22/2026 at 23:10, 1 hour 34 minutes ago Global Atomic Announces Proposed Public Offering of Units
Published on 09/22/2026 at 22:30, 2 hours 14 minutes ago Silver Spruce Receives TSXV Conditional Approval of Debt Settlement
Published on 09/22/2026 at 22:01, 2 hours 43 minutes ago Fermi and TensorWave Agree to Extend Closing Date to October 31, 2026
Published on 09/22/2026 at 19:40, 5 hours 3 minutes ago EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 5 hours 44 minutes ago LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:45, 5 hours 58 minutes ago MGI Digital Technology: Modification des ressources allouées au contrat de liquidité.
Published on 09/22/2026 at 18:30, 6 hours 14 minutes ago Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 18:30, 6 hours 14 minutes ago Voyageurs du Monde: Communiqué sur le dépôt de projet de note en réponse (suite au dépôt de projet de note en réponse de Voyageurs du Monde à l'Autorité des Marchés Financiers)
Published on 09/22/2026 at 18:00, 6 hours 44 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 6 hours 44 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 6 hours 59 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/22/2026 at 17:45, 6 hours 59 minutes ago Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026
